Standardized prostate cancer incidence and mortality rates following initial non‐malignant biopsy result

• Published in: BJU international Vol. 132; no. 2; pp. 181 - 187
• Main Authors: Stroomberg, Hein V., Andersen, Marc C.M., Helgstrand, John Thomas, Larsen, Signe Benzon, Vickers, Andrew J., Brasso, Klaus, Røder, Andreas
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.08.2023
• Subjects: Age groups; Biopsy; DaPCaR; disease‐specific mortality; epidemiology; Humans; Image-Guided Biopsy; Incidence; Male; Middle Aged; Mortality; non‐malignant histology; NORDCAN; PCSM; Prostate - pathology; Prostate cancer; Prostate-Specific Antigen; ProstateCancer; Prostatic Neoplasms - pathology; TRUS biopsy; uroonc; epidemiology; uroonc; DaPCaR; NORDCAN; PCSM; ProstateCancer; disease-specific mortality; TRUS biopsy; incidence; non-malignant histology
• ISSN: 1464-4096; 1464-410X; 1464-410X
• DOI: 10.1111/bju.15997

Objectives To compare the incidence of subsequent prostate cancer diagnosis and death following an initial non‐malignant systematic transrectal ultrasonography (TRUS) biopsy with that in an age‐ and calendar‐year matched population over a 20‐year period. Subjects and Methods This population‐based an...